Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 43,258 | 31,643 | 21,647 | 17,072 | 7,035 |
| Cost of Goods | 11,810 | 12,867 | 13,458 | 10,253 | 4,830 |
| Gross Profit | 31,448 | 18,776 | 8,190 | 6,819 | 2,205 |
| Operating Expenses | 95,577 | 84,026 | 68,752 | 70,071 | 49,063 |
| Operating Income | -63,319 | -64,383 | -60,105 | -62,999 | -46,028 |
| Interest Expense | 0 | 0 | 58 | 72 | 415 |
| Other Income | 18,855 | 11,111 | 1,573 | 14 | 166 |
| Pre-tax Income | -44,464 | -53,272 | -58,590 | -63,057 | -46,277 |
| Income Tax | 845 | 956 | -8,509 | -8,864 | -4,486 |
| Net Income Continuous | -45,309 | -54,228 | -50,081 | -54,193 | -41,790 |
| Net Income | $-45,309 | $-54,228 | $-50,081 | $-54,193 | $-41,790 |
| EPS Basic Total Ops | -0.98 | -1.46 | -1.55 | -1.83 | -1.53 |
| EPS Basic Continuous Ops | -0.98 | -1.46 | -1.56 | -1.83 | -1.53 |
| EPS Diluted Total Ops | -0.98 | -1.46 | -1.55 | -1.83 | -1.53 |
| EPS Diluted Continuous Ops | -0.98 | -1.46 | -1.56 | -1.83 | -1.53 |
| EPS Diluted Before Non-Recurring Items | -0.99 | -1.45 | -1.56 | -1.83 | -0.40 |
| EBITDA(a) | $-62,726 | $-63,762 | $-59,509 | $-62,412 | $-45,391 |